Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, September 30 2016 8:56pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Friday, Sep 30, 2016
·NEOS INVESTOR ALERT: The Law Offices of Vincent Wong Launches Investigation of Neos Therapeutics, Inc. for Possible Securities Fraud Violations
Business Wire - 15 minutes ago
·Mylan Launches Generic Fortamet® Tablets
PR Newswire - Fri 9:50 am ET
·Zoetis to Host Webcast and Conference Call on Third Quarter 2016 Financial Results
Business Wire - Fri 8:30 am ET
Thursday, Sep 29, 2016
·Galectin Tanks on Failure of NASH Treatment (GALT)
at Investopedia - Thu 4:05 pm ET
·Galectin Therapeutics (GALT) Stock Drops on Drug Failure, Downgraded
at - Thu 2:13 pm ET
·Most Americans think prescription drugs are too expensive, but few actually struggle to pay
at MarketWatch - Thu 1:39 pm ET
·Mylan Woes Pushing Stock Back Toward 52-Week Low
- Thu 11:45 am ET
·Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
PR Newswire - Thu 9:28 am ET
·Horizon Pharma to pay Express Scripts $65 mln to settle rebate litigation
Reuters - Thu 9:22 am ET
·Flexion Therapeutics Announces Appointment of John Magee as Vice President of Sales
GlobeNewswire - Thu 8:30 am ET
·Horizon Pharma plc Provides Update on PBM Formulary Status for Primary Care Medicines
GlobeNewswire - Thu 8:00 am ET
·Fibrocell to Present at 2016 Cell & Gene Meeting on the Mesa
GlobeNewswire - Thu 8:00 am ET
·MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript
Marketwire - Thu 8:00 am ET
·Karyopharm Publishes Preclinical Data in Nature Demonstrating Selinexor’s Potential in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
GlobeNewswire - Thu 7:30 am ET
·Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER
GlobeNewswire - Thu 7:00 am ET
·EpiPen’s $69 Cost in Britain Shows Other Extreme of Drug Pricing
at Bloomberg - Thu 1:00 am ET
·The cost of cheap drugs? Toxic Indian lake is "superbug hotspot"
Reuters - Wed 7:00 pm ET
·U.S. agency told Mylan that EpiPen was misclassified
Reuters - Wed 6:40 pm ET
Wednesday, Sep 28, 2016
·U.S. agency says it advised Mylan that EpiPen was misclassified
Reuters - Wed 4:57 pm ET
·A Modest Proposal To Reduce The Price of EpiPens
at - Wed 4:55 pm ET
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?